Why the Cochrane Risk of Bias Tool Should not Include Funding Source as a Standard Item

Sterne, Jonathan AC

doi:10.1002/14651858.ed000076

Cited by 60Meta-analysis and systematic reviewsPharmaceutical industry and healthcareStatistical Methods in Epidemiology

Why the Cochrane Risk of Bias Tool Should not Include Funding Source as a Standard Item

Open access

Sterne, Jonathan AC·2013·Cochrane Database of Systematic Reviews

DOI 10.1002/14651858.ed000076PMC PMC10897924

Open this paper in CoChat — free account Open PDF

Abstract

This editorial is based on a

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/14651858.ed000076

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The rationale for not including financial conflicts of interest in ROBINS-E is that if financial conflicts of interest lead to bias then this will operate through one of the domains already in the tool.
“The rationale, previously discussed in the context of randomized trials (Sterne, 2013), is that if financial conflicts of interest lead to bias then this will operate through one of the domains already in the tool.”
From A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E) (2024) · cites this paper as Sterne, 2013

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Why the Cochrane Risk of Bias Tool Should Include Funding Source as a Standard Item
Bero, L. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.ed000075 · Cited by 96 · see citing works
Neuraminidase inhibitors--the story behind the Cochrane review
Doshi, P. (2009) · BMJ · doi:10.1136/bmj.b5164 · Cited by 86 · see citing works
AbbVie considers harms to be commercially confidential information: sign a petition
Gøtzsche, P. C. (2013) · BMJ · doi:10.1136/bmj.f7569 · Cited by 3 · see citing works

Flagged first, then by citations

Research works printed but not linked: 1

Higgins JPT, Altman DG, Sterne JAC on behalf of the COchrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at handbook.cochrane.org.

Sorted by citations

A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)
Higgins, J. P. T., Morgan, R. L., Rooney, A. A., Taylor, K. W., Thayer, K. A., Silva, R. A., Lemeris, C., Akl, E. A., Bateson, T. F., Berkman, N. D., et al. (2024) · Environment International · doi:10.1016/j.envint.2024.108602 · Cited by 1,022 · see citing works
“The rationale, previously discussed in the context of randomized trials (Sterne, 2013), is that if financial conflicts of interest lead to bias then this will operate through one of the domains already in the tool.”
Self-citation
Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle–Ottawa Scale and the RTI item bank
Margulis, A. V., Pladevall, M., Riera‐Guàrdia, N., Varas‐Lorenzo, C., Hazell, L., Berkman, N. D., Viswanathan, M., & Perez‐Gutthann, S. (2014) · Clinical Epidemiology · doi:10.2147/clep.s66677 · Cited by 441 · see citing works
The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: a systematic review with network meta-analyses of randomised trials
Catalá-López, F., Hutton, B., Núñez-Beltrán, A., Page, M. J., Ridao, M., Macías Saint-Gerons, D., Catalá, M. A., Tabarés-Seisdedos, R., & Moher, D. (2017) · PLOS ONE · doi:10.1371/journal.pone.0180355 · Cited by 396 · see citing works
Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews
Jørgensen, L., Paludan-Müller, A. S., Laursen, D. R. T., Savović, J., Boutron, I., Sterne, J. A. C., Higgins, J. P. T., & Hróbjartsson, A. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0259-8 · Cited by 396 · see citing works
Self-citation
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Ramstad, E., Krogh, H. B., Nilausen, T. D., Skoog, M., Holmskov, M., Rosendal, S., Groth, C., Magnusson, F. L., Moreira-Maia, C. R., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub2 · Cited by 347 · see citing works
Investigating and dealing with publication bias and other reporting biases in meta-analyses of health research: a review
Page, M. J., Sterne, J. A. C., Higgins, J. P. T., & Egger, M. (2021) · Research Synthesis Methods · doi:10.1002/jrsm.1468 · Cited by 294 · see citing works
Self-citation
The Cochrane risk of bias assessment tool 2 (RoB 2) versus the original RoB: A perspective on the pros and cons
Nejadghaderi, S. A., Balibegloo, M., & Rezaei, N. (2024) · Health Science Reports · doi:10.1002/hsr2.2165 · Cited by 263 · see citing works
Considering bias and conflicts of interest among the included studies
Boutron, I., Page, M. J., Higgins, J. P., Altman, D. G., Lundh, A., Hróbjartsson, A., & on behalf of the Cochrane Bias Methods Group (2019) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9781119536604.ch7 · Cited by 258 · see citing works
The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Integration of Animal and Human Evidence for PFOA Effects on Fetal Growth
Lam, J., Koustas, E., Sutton, P., Johnson, P. I., Atchley, D. S., Sen, S., Robinson, K. A., Axelrad, D. A., & Woodruff, T. J. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1307923 · Cited by 214 · see citing works
Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Punja, S., Shamseer, L., Hartling, L., Urichuk, L., Vandermeer, B., Nikles, J., & Vohra, S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009996.pub2 · Cited by 122 · see citing works
Pharmacological interventions for people with borderline personality disorder
Stoffers‐Winterling, J., Storebø, O. J., Ribeiro, J. P., Kongerslev, M., Vӧllm, B., Mattivi, J. T., Faltinsen, E. G., Todorovac, A., Jørgensen, M. S., Edemann-Callesen, H., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012956.pub2 · Cited by 118 · see citing works
Systemic antibiotics for treating diabetic foot infections
Selva, A., Solà, I., Barajas-Nava, L. A., Gianneo, O. D., Bonfill, X., & Lipsky, B. A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009061.pub2 · Cited by 101 · see citing works
How credible are the study results? Evaluating and applying internal validity tools to literature-based assessments of environmental health hazards
Rooney, A. A., Cooper, G. S., Jahnke, G. D., Lam, J., Morgan, R. L., Boyles, A. L., Ratcliffe, J. M., Kraft, A. D., Schünemann, H. J., Schwingl, P. J., et al. (2016) · Environment International · doi:10.1016/j.envint.2016.01.005 · Cited by 95 · see citing works
Antibiotic therapy for pelvic inflammatory disease
Savaris, R. F., Fuhrich, D. G., Maissiat, J., Duarte, R. V., & Ross, J. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010285.pub3 · Cited by 81 · see citing works
Effect of standardized training on the reliability of the Cochrane risk of bias assessment tool: a prospective study
da Costa, B. R., Beckett, B., Diaz, A., Resta, N. M., Johnston, B. C., Egger, M., Jüni, P., & Armijo-Olivo, S. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0441-7 · Cited by 62 · see citing works
Antibiotic therapy for pelvic inflammatory disease
Savaris, R. F., Fuhrich, D. G., Duarte, R. V., Franik, S., & Ross, J. D. C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010285.pub2 · Cited by 66 · see citing works
Rethinking the assessment of risk of bias due to selective reporting: a cross-sectional study
Page, M. J., & Higgins, J. P. T. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0289-2 · Cited by 60 · see citing works
The judgement of biases included in the category “other bias” in Cochrane systematic reviews of interventions: a systematic survey
Babić, A., Pijuk, A., Brázdilová, L., Georgieva, Y., Pereira, M. A. R., Peričić, T. P., & Puljak, L. (2019) · BMC Medical Research Methodology · doi:10.1186/s12874-019-0718-8 · Cited by 60 · see citing works
Modified intention-to-treat analysis did not bias trial results
Døssing, A., Tarp, S., Furst, D. E., Gluud, C. N., Wells, G. A., Beyene, J., Hansen, B. B., Bliddal, H., & Christensen, R. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.11.003 · Cited by 55 · see citing works
Comparisons of exacerbations and mortality among regular inhaled therapies for patients with stable chronic obstructive pulmonary disease: Systematic review and Bayesian network meta-analysis
Lee, H. W., Park, J., Jo, J., Jang, E. J., & Lee, C. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002958 · Cited by 51 · see citing works
Injection therapies for plantar fasciopathy (‘plantar fasciitis’): a systematic review and network meta-analysis of 22 randomised controlled trials
Tsikopoulos, K., Vasiliadis, H. S., & Mavridis, D. (2016) · British Journal of Sports Medicine · doi:10.1136/bjsports-2015-095437 · Cited by 47 · see citing works
Industry Support of Medical Research: Important Opportunity or Treacherous Pitfall?
Tierney, W. M., Meslin, E. M., & Kroenke, K. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3495-z · Cited by 44 · see citing works
Randomized clinical trials in dentistry: Risks of bias, risks of random errors, reporting quality, and methodologic quality over the years 1955-2013
Saltaji, H., Armijo-Olivo, S., Cummings, G. G., Amin, M., & Flores-Mir, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0190089 · Cited by 43 · see citing works
Methylphenidate for ADHD in children and adolescents: throwing the baby out with the bathwater
Banaschewski, T., Buitelaar, J., Chui, C. S. L., Coghill, D., Cortese, S., Simonoff, E., & Wong, I. C. K. (2016) · Evidence Based Mental Health · doi:10.1136/eb-2016-102461 · Cited by 35 · see citing works
When poorly conducted systematic reviews and meta-analyses can mislead: a critical appraisal and update of systematic reviews and meta-analyses examining the effects of probiotics in the treatment of functional constipation in children
Harris, R. G., Neale, E. P., & Ferreira, I. (2019) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz071 · Cited by 38 · see citing works
What are the benefits of methylphenidate as a treatment for children and adolescents with attention-deficit/hyperactivity disorder?
Gerlach, M., Banaschewski, T., Coghill, D., Rohde, L. A., & Romanos, M. (2017) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-017-0220-2 · Cited by 23 · see citing works
Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009
Benea, C., Turner, K. A., Roseman, M., Bero, L. A., Lexchin, J., Turner, E. H., & Thombs, B. D. (2020) · Systematic Reviews · doi:10.1186/s13643-020-01318-5 · Cited by 22 · see citing works
Interpreting trial results following use of different intention-to-treat approaches for preventing attrition bias: a meta-epidemiological study protocol
Døssing, A., Tarp, S., Furst, D. E., Gluud, C. N., Beyene, J., Hansen, B. B., Bliddal, H., & Christensen, R. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005297 · Cited by 21 · see citing works
Comparative effectiveness and safety of eribulin in advanced or metastatic breast cancer: a systematic review and meta-analysis
Tanni, K. A., Truong, B., Johnson, B., & Qian, J. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103375 · Cited by 20 · see citing works
Determining the optimal duration of plyometric training for enhancing vertical jump performance: a systematic review and meta-analysis
Kumar, D., Dhull, S., Nara, K., & Kumar, P. (2023) · Health sport rehabilitation · doi:10.58962/hsr.2023.9.3.118-133 · Cited by 19 · see citing works
Effectiveness of probiotics and synbiotics in reducing duration of acute infectious diarrhea in pediatric patients in developed countries: a systematic review and meta-analysis
Vassilopoulou, L., Spyromitrou-Xioufi, P., & Ladomenou, F. (2021) · European Journal of Pediatrics · doi:10.1007/s00431-021-04046-7 · Cited by 22 · see citing works
Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study
Turner, K. A., Carboni-Jiménez, A., Benea, C., Elder, K., Levis, B., Boruff, J. T., Roseman, M., Bero, L. A., Lexchin, J., Turner, E. H., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035633 · Cited by 17 · see citing works
Pharmacological interventions for people with borderline personality disorder
Stoffers-Winterling, J. M., Storebø, O. J., Vӧllm, B., Mattivi, J. T., Nielsen, S. S., Kielsholm, M. L., Faltinsen, E. G., Simonsen, E. H., & Lieb, K. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012956 · Cited by 18 · see citing works
Systematic review finds that appraisal tools for medical research studies address conflicts of interest superficially
Lundh, A., Rasmussen, K., Østengaard, L., Boutron, I., Stewart, L. A., & Hróbjartsson, A. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.12.005 · Cited by 15 · see citing works
A Politics of Objectivity: Biomedicine’s Attempts to Grapple with “non-financial” Conflicts of Interest
Grundy, Q. (2021) · Science and Engineering Ethics · doi:10.1007/s11948-021-00315-8 · Cited by 13 · see citing works
Effect of standardized training on the reliability of the Cochrane risk of bias assessment tool: a study protocol
da Costa, B. R., Resta, N. M., Beckett, B., Israel-Stahre, N., Diaz, A., Johnston, B. C., Egger, M., Jüni, P., & Armijo-Olivo, S. L. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-144 · Cited by 13 · see citing works
The effect of indapamide vs. bendroflumethiazide for primary hypertension: a systematic review
Macfarlane, T. V., Pigazzani, F., Flynn, R., & MacDonald, T. M. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13787 · Cited by 13 · see citing works
Commercial funding and estimated intervention effects in randomized clinical trials: Systematic review of meta‐epidemiological studies
Nejstgaard, C. H., Laursen, D. R. T., Lundh, A., & Hróbjartsson, A. (2022) · Research Synthesis Methods · doi:10.1002/jrsm.1611 · Cited by 12 · see citing works
Evidence on methylphenidate in children and adolescents with ADHD is in fact of ‘very low quality’
Storebø, O. J., Zwi, M., Krogh, H. B., Maia, C. R. M., Holmskov, M., Gillies, D. M., Groth, C., Simonsen, E. H., & Gluud, C. N. (2016) · Evidence-Based Mental Health · doi:10.1136/eb-2016-102499 · Cited by 11 · see citing works
The advantage and disadvantage of body composition on athletic success: A kabaddi player perspective
Kumar, D., Nara, K., & Dhull, S. (2023) · International Journal of Yogic Human Movement and Sports Sciences · doi:10.22271/yogic.2023.v8.i2c.1448 · Cited by 9 · see citing works
Conflicts of interest in nutritional sciences: The forgotten bias in meta-analysis
Lucas, M. (2015) · World Journal of Methodology · doi:10.5662/wjm.v5.i4.175 · Cited by 9 · see citing works
Quality assessment of systematic reviews and meta-analyses that examine preventive antibiotic uses and management practices designed to prevent disease in livestock
Vriezen, R., Sargeant, J. M., Vriezen, E. R., Winder, C. B., & O'Connor, A. M. C. (2019) · Animal Health Research Reviews · doi:10.1017/s146625231900029x · Cited by 9 · see citing works
Investigating and Dealing with Publication Bias and Other Reporting Biases
Page, M. J., Sterne, J. A. C., Higgins, J. P. T., & Egger, M. (2022) · Wiley eBooks · doi:10.1002/9781119099369.ch5 · Cited by 9 · see citing works
Self-citation
How about the evidence assessment tools used in education and management systematic reviews?
Lan, H., Yu, X., Wang, Z., Wang, P., Sun, Y., Wang, Z., Su, R., Wang, L., Zhao, J., Hu, Y., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1160289 · Cited by 8 · see citing works
DEPERROR: Risks of systematic errors in drug and non-drug randomized clinical trials assessing intervention effects in patients with unipolar depression
Krogh, J., Hjorthøj, C. R., Jakobsen, J. C., Lindschou, J., Kessing, L. V., Nordentoft, M., & Gluud, C. N. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.042 · Cited by 8 · see citing works
Using risk of bias domains to identify opportunities for improvement in food- and nutrition-related research: An evaluation of research type and design, year of publication, and source of funding
Myers, E. F., Parrott, J. S., Splett, P. L., Chung, M., & Handu, D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197425 · Cited by 8 · see citing works
Outcomes of Minimally Invasive Glaucoma Surgery (MIGS) in Glaucoma Patients With Coexisting Cataract: A Systematic Review and Meta-Analysis
Bidiwala, S., Jabarkhyl, D., & Bidiwala, K. (2025) · Cureus · doi:10.7759/cureus.77007 · Cited by 7 · see citing works
Associations between industry involvement and study characteristics at the time of trial registration in biomedical research
Seidler, A., Hunter, K., Chartres, N., & Askie, L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222117 · Cited by 7 · see citing works
Should clinical automated perimetry be considered for routine functional assessment of early/intermediate age‐related macular degeneration (AMD)? A systematic review of current literature
Trinh, M., Kalloniatis, M., & Nivison‐Smith, L. (2021) · Ophthalmic and Physiological Optics · doi:10.1111/opo.12919 · Cited by 5 · see citing works
Effects of Herbal Tea (Non–Camellia sinensis) on Glucose Homeostasis and Serum Lipids in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Zarasvand, S. A., Ogawa, S., Nestor, B., Bridges, W. C., & Haley‐Zitlin, V. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuae068 · Cited by 4 · see citing works
Response to: The evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder is in fact flawed
Hoekstra, P. J., & Buitelaar, J. K. (2016) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-016-0856-z · Cited by 3 · see citing works
Judgments of other bias in Cochrane systematic reviews of interventions are highly inconsistent and thus hindering use and comparability of evidencePreprint
Babić, A., Pijuk, A., Brázdilová, L., Georgieva, Y., Pereira, M. A. R., Peričić, T. P., & Puljak, L. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/366591 · Cited by 3 · see citing works
Effect of Biologic Therapies in Treating Moderate-to-Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis
Thadiboina, O., Shah, S. S. A., Ray, R., Hack, S. A., Munir, M., Shah, Q., Bhullar, A., Shah, S. Z. H., Ali, M., Nureen, U., et al. (2025) · Cureus · doi:10.7759/cureus.85923 · Cited by 2 · see citing works
The Impact of Drug Trials With Financial Conflict of Interests on the Meta-analyses: A Meta-epidemiological Study
Zhang, N., Yan, P., Zhao, H., Feng, L., Chu, X., Li, J., Chen, N., Yang, K., & Liu, X. (2021) · International Journal of Health Policy and Management · doi:10.34172/ijhpm.2021.162 · Cited by 2 · see citing works
Conflict of interest and risk of bias in systematic reviews on methylphenidate for attention-deficit hyperactivity disorder: a cross-sectional study
Snellman, A., Carlberg, S., & Olsson, L. (2023) · Systematic Reviews · doi:10.1186/s13643-023-02342-x · Cited by 2 · see citing works
Reply to Khan et al.
Schwingshackl, L., Neuenschwander, M., HOFFMANN, G. E., Buyken, A. E., & Schlesinger, S. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa006
Assessment of the Risk of Bias
Moon, K., & Rao, S. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-71921-0_4
Addressing Conflicts of Interest in Clinical Trials
Lundh, A., & Hróbjartsson, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-27479-3_6
Artificial intelligence enabled social robotic interventions (PARO) in Australian dementia care: A systematic review and meta-analysis
Omar, S. H., Ghani, A., Sanober, A., & Umar, A. (2026) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2026.106627
Efficacy of virtual reality-based exposure therapy for post-traumatic stress disorder in military veterans: a systematic review and meta-analysis
Felemban, R. G., Alzahrani, R. R., Alrefaei, N. F., Alharbi, N. M., Alghamdi, A. S., & Alqadi, S. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1857109 · Cited by 1 · see citing works

Authors: Sterne, J. A.
Affiliations: University of Bristol (GB)
Corresponding author: Sterne, Jonathan AC
ORCID: Sterne, Jonathan AC
Venue: Cochrane Database of Systematic Reviews
Publisher: John Wiley & Sons, Ltd
Published: 2013-12-20
Issue: 12
Pages: ED000076-ED000076
ISSN: 1361-6137 (ISSN-L)
DOI: 10.1002/14651858.ed000076
PMC: PMC10897924
OpenAlex: W2763135972
Cited by: 60
References: 3
Citations by year: 2026: 3 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 7 · 2018: 4 · 2017: 5 · 2016: 8 · 2015: 6 · 2014: 4
Type: reference entry
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Cochrane Database of Systematic Reviews (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Bristol Research (University of Bristol) (publishedVersion)
Explore Bristol Research (submittedVersion)
Topics: Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmaceutical industry and healthcare
Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
Keywords: Cochrane risk of bias tool, funding sources, risk of bias assessment, conflicts of interest, research funding disclosure, systematic review methodology
MeSH terms: Drug Industry, Research Support as Topic, Review Literature as Topic, Risk, Conflict of Interest, Publication Bias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Why the Cochrane Risk of Bias Tool Should not Include Funding Source as a Standard Item

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks